NVAX

7.4703.24%
EO

Elaine O'Hara

Executive VP & Chief Strategy Officer

Ms. Elaine O'Hara has been Head of North America Commercial Operations for Sanofi Pasteur at Sanofi-Aventis U.S. LLC. She is Executive Vice President, Chief Strategy Officer at Novavax, Inc. Ms. O'Hara has been Senior Vice President of Sales & Marketing Otsuka America Pharmaceutical, Inc. since May 5, 2016. Ms. O'Hara served as Vice President of U.S. Marketing of Otsuka America Pharmaceutical, Inc. until May 5, 2016. Ms. O'Hara served as Vice President of U.S. CNS Portfolio Marketing of Otsuka America Pharmaceutical, Inc. She has U.S. commercial responsibility for ABILIFY® (aripiprazole), Abilify Maintena® (aripiprazole) and related strategic portfolio commercial alliances. She has more than 20 years of experience in executive strategic, marketing and business operations in the pharmaceutical industry. She joined Otsuka in 2012 as strategic lead for the renal-cardiovascular commercial business. She spent 14 years at Wyeth/Pfizer. Her last position in that organization was Anti-infective Portfolio Commercial Lead in the U.S. Specialty Care business. At Wyeth, she held a series of leadership positions in the vaccine, anti-infective and transplant franchises. She worked in product management at Astra/Merck and was a Senior Consultant at Andersen Consulting (Accenture). Ms. O'Hara served as Director of Steel Jupiter, Inc. since May 04, 2021 until August 2026. Ms. O'Hara earned a B.A. degree in Music and French from National University of Ireland, Maynooth and an M.B.A. degree with a concentration in Marketing from the Haub School of Business, Saint Joseph's University.

Positions